Xeris Biopharma Holdings
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-34.31118.0822.1813.81
Price/Sales ratio
4.143.472.962.55
Earnings per Share (EPS)
$-0.21$0.06$0.33$0.53

Historical Multiples (2017 – 2023)

2017 2020 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.54-1.70-1.90-5.19-2.97-1.90
Price/Sales ratio
26.354.231.631.972.552.55
Price/Book Value ratio
-0.702.203.99-47.706.222.20
Price/Cash Flow ratio
-1.66-2.19-1.75-6.88-2.73-1.75
Price/Free Cash Flow ratio
-1.61-2.17-1.74-6.56-2.72-1.74
Price/Earnings Growth ratio
-0.010.090.040.14-0.050.04
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
99.74%73.14%79.46%82.52%79.46%73.14%
Operating Profit Margin
-1711.37%-232.21%-74.32%-26.84%-74.32%-232.21%
Pretax Profit Margin
-1706.55%-247.47%-87.15%-38.74%-87.15%-247.47%
Net Profit Margin
-1706.55%-247.47%-85.86%-37.98%-85.86%-247.47%
Effective Tax Rate
-0.00%0.08%1.48%1.96%0.77%0.08%
Return on Assets
-59.01%-40.32%-27.47%-19.29%-27.47%-40.32%
Return On Equity
45.91%-128.87%-209.48%917.94%-139.91%-139.91%
Return on Capital Employed
-66.34%-51.10%-30.24%-19.35%-30.24%-51.10%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A2.53N/A
Quick Ratio
9.061.572.201.232.071.57
Cash ratio
8.650.851.650.701.650.85
Days of Sales Outstanding
281.2550.60102.0687.28102.0650.60
Days of Inventory outstanding
0.09496.55398.88494.88398.88398.88
Operating Cycle
281.34547.15500.95582.16424.04500.95
Days of Payables Outstanding
180.31K85.4274.27147.3674.2774.27
Cash Conversion Cycle
-180.02K461.72426.67434.80126.14426.67
Debt Ratios
Debt Ratio
N/A0.280.540.600.860.28
Debt Equity Ratio
N/A0.914.17-28.666.620.91
Long-term Debt to Capitalization
N/A0.470.801.030.810.47
Total Debt to Capitalization
N/A0.470.801.030.810.47
Interest Coverage Ratio
N/AN/AN/AN/A-5.34N/A
Cash Flow to Debt Ratio
N/A-1.09-0.54-0.24-0.51-1.09
Company Equity Multiplier
-0.773.197.62-47.567.623.19
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-15.85-1.92-0.93-0.28-0.93-1.92
Free Cash Flow / Operating Cash Flow Ratio
1.021.011.001.041.001.00
Cash Flow Coverage Ratio
N/A-1.09-0.54-0.24-0.51-1.09
Short Term Coverage Ratio
N/AN/A-65.12-13.45-65.12-65.12
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A